Search

Your search keyword '"Worm, Margitta"' showing total 478 results

Search Constraints

Start Over You searched for: Author "Worm, Margitta" Remove constraint Author: "Worm, Margitta" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
478 results on '"Worm, Margitta"'

Search Results

4. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.

6. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials

9. Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial

11. Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee

12. Age- and Elicitor-Dependent Characterization of Hymenoptera Venom-Induced Anaphylaxis in Children and Adolescents

13. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

16. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis

19. Global disparities in availability of epinephrine auto-injectors

21. Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis

22. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry

28. Managing food allergy: GA2LEN guideline 2022

33. Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study

34. Tolerance induction through early feeding to prevent food allergy in infants with eczema (TEFFA): rationale, study design, and methods of a randomized controlled trial

35. Autologous hematopoietic stem cell transplantation improves long-term survival—data from a national registry

36. Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials.

37. Management of Refractory Anaphylaxis: An Overview of Current Guidelines.

38. Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis

39. Title of Article: Response to Correspondence ALL-2023-01107 “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy”

40. S2k guideline: Diagnosis and therapy of localized scleroderma

41. 561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial

42. 566 - Efficacy of dupilumab treatment in atopic hand and foot dermatitis across morphological subtypes: results from a phase 3, randomized, double-blind, placebo-controlled trial

43. Food allergy outside the eight big foods in Europe: A systematic review and meta‐analysis

44. Global distribution of physician-diagnosed adult-onset food allergy: results from the international, cross-sectional prevalence and severity study of pediatric and adult IgE-mediated food allergies (ASSESS FA)

45. 523 - Efficacy and safety of amlitelimab (an anti-OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 24-week results from a phase 2b trial (STREAM-AD)

46. Risk Stratification of Food Allergy Patients: Results from the International, Cross-sectional Prevalence and Severity Study of Pediatric and Adult IgE-Mediated Food Allergies (ASSESS FA)

47. S3‐Leitlinie Atopische Dermatitis: Teil 2 ‐ Systemische Therapie

48. S3 Guideline Atopic dermatitis: Part 1 ‐ General aspects, topical and non‐drug therapies, special patient groups

49. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

50. Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus

Catalog

Books, media, physical & digital resources